Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

AstraZeneca escapes pandemic impact as new drugs bolster revenues

AstraZeneca escapes pandemic impact as new drugs bolster revenues

Sales in AZ’s respiratory franchise were also better-than-expected, with sales of asthma treatment Symbicort (budesonide and formoterol fumarate dihydrate) increasing by 12% to bring in $653m – around $90m

GSK forges ahead with its dynamic COPD and asthma portfolio

GSK forges ahead with its dynamic COPD and asthma portfolio For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

New hires at Crescendo, Healx and Galecto

New hires at Crescendo, Healx and Galecto In that role, he led the development of Symbicort, a leading respiratory brand.

AZ reports growth again in Q3, driven by oncology and China sales

AZ reports growth again in Q3, driven by oncology and China sales AZ’s respiratory franchise also grew 18% to $1.3bn – although the company saw a 4% decline in sales of Symbicort, this was offset by the growth of Pulmicort and Fasenra,

AZ builds case for its COPD triple as it chases GSK’s Trelegy

AZ builds case for its COPD triple as it chases GSK’s Trelegy reduction versus older drug Symbicort (formoterol fumarate/budesonide).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics